ESC Premium Access

Is there evidence of a rebound increase in platelet aggregation following withdrawal of Aspirin or Ticagrelor in patients who have previously undergone PCI and coronary stenting?

Congress Presentation

About the speaker

Doctor Barry Hennigan

The Mater Private Hospital Cork, Cork (Ireland)
0 follower

5 more presentations in this session

Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention

Speaker: Doctor K. Adatia (Cambridge, GB)


Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

Speaker: Professor F. Beygui (Caen, FR)


Effect of exercise stress test on platelet function in patients with recent acute myocardial infarction

Speaker: Doctor T. Dalcoquio (Sao Paulo, BR)


Comparative efficacy of intracoronary agents for acute treatment of coronary no-reflow: a network meta-analysis

Speaker: Associate Professor G. Klappacher (Vienna, AT)


Late mortality after pharmaco-invasive PCI for STEMI

Speaker: Professor J. French (Sydney, AU)


Access the full session

Pharmaco intervention and mechanisms in acute coronary syndromes

Speakers: Doctor B. Hennigan, Doctor K. Adatia, Professor F. Beygui, Doctor T. Dalcoquio, Associate Professor G. Klappacher...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb